Jakob Anninga
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Oncology
- Rheumatology top 5%
- Cancer Research top 10%
- Co-authors
- Hans GelderblomPancras C.W. HogendoornMarta FioccoR. Maarten EgelerA. H. M. TaminiauJudith R. KroepJan OostingJelle J. Goeman
- Topics
- Sarcoma Diagnosis and Treatment (11 papers)Bone Tumor Diagnosis and Treatments (6 papers)Cancer Genomics and Diagnostics (4 papers)
- Journals
- International Journal of Radiation Oncology*Biology*PhysicsEuropean Journal of CancerBMJ Open
- Partner nations
- NetherlandsUnited KingdomItaly
In The Last Decade
Jakob Anninga
20 papers receiving 816 citations
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 406
- Molecular Biology 312
- Oncology 189
- Rheumatology 172
- Cancer Research 168
Countries citing papers authored by Jakob Anninga
This map shows the geographic impact of Jakob Anninga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Anninga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Anninga more than expected).
Fields of papers citing papers by Jakob Anninga
This network shows the impact of papers produced by Jakob Anninga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Anninga. The network helps show where Jakob Anninga may publish in the future.
Co-authorship network of co-authors of Jakob Anninga
This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Anninga. A scholar is included among the top collaborators of Jakob Anninga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Anninga. Jakob Anninga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 6 | |
| 4 | 15 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 19 | |
| 8 | 6 | |
| 9 | 7 | |
| 10 | Causal inference with randomised clinical trials of chemotherapy: The importance of well-documented treatment side-effects | 1 |
| 11 | 60 | |
| 12 | Clinical and molecular features of high-grade osteosarcoma | 1 |
| 13 | 21 | |
| 14 | 13 | |
| 15 | 316 | |
| 16 | 37 | |
| 17 | 72 | |
| 18 | 118 | |
| 19 | 57 | |
| 20 | 65 |
About Jakob Anninga
Jakob Anninga is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 20 papers that have together received 834 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Bone Tumor Diagnosis and Treatments (6 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (406 citations), Rheumatology (172 citations) and Cancer Research (168 citations). Jakob Anninga has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include Hans Gelderblom, Pancras C.W. Hogendoorn, Marta Fiocco, R. Maarten Egeler, A. H. M. Taminiau, Judith R. Kroep, Jan Oosting, Jelle J. Goeman, Anne‐Marie Cleton‐Jansen and Hans C. van Houwelingen. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.